Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPALT: Multimodal Fall Prevention in Elderly with Impaired Renal Function
NCT00483275Phase 4Withdrawn
- Sponsor
- Ruhr University Bochum
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alfacalcidol in chronic kidney disease (CKD) and accidental falls (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Number of fallers at 1 year. Planned start Jun 2007; status: withdrawn.
02
Drugs
alfacalcidol
03
Conditions
chronic kidney disease (CKD)accidental falls
Beyond the preview
Go deeper on NCT00483275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483275.